BACKGROUND: A previous case report of West Nile virus (WNV) illness during pregnancy suggested that WNV could be a cause of congenital defects. We performed a prospective, longitudinal cohort study of pregnant women with WNV illness to increase our knowledge of the effects of WNV illness during pregnancy. METHODS: Participants were enrolled in 2005 to 2008 from pregnant women with serologically confirmed WNV illness reported to the Centers for Disease Control and Prevention. Comparison was made to WNV-uninfected women, matched on maternal age and enrollment month. Pregnancy and newborn data were collected; cord blood WNV serology was obtained. Pediatric exams and the Bayley Scales of Infant and Toddler Development-Third Edition (Bayley-III) were performed. RESULTS: Twenty-eight WNV-infected mothers and 25 WNV-uninfected mothers participated. Maternal demographics were similar except for a higher rate of planned pregnancies, education, and household income in the WNV-uninfected mothers. There were no differences in pregnancy and delivery characteristics except that infected mothers had a higher incidence of febrile illnesses and used more medications. Birth weight, length, head circumference, and rate of congenital malformations were similar in babies born to WNV-infected and -uninfected mothers. Follow-up physical exams were generally normal. The Bayley-III assessments, available for 17 children born to mothers with WNV illness, showed performance at or above age level across domains. CONCLUSION: The risk for adverse pregnancy and newborn outcomes in women experiencing WNV illness in pregnancy appears to be low, but future studies with larger numbers are needed to rule out a small risk. Birth Defects Research (Part A) 106:716-723, 2016.
BACKGROUND: A previous case report of West Nile virus (WNV) illness during pregnancy suggested that WNV could be a cause of congenital defects. We performed a prospective, longitudinal cohort study of pregnant women with WNV illness to increase our knowledge of the effects of WNV illness during pregnancy. METHODS:Participants were enrolled in 2005 to 2008 from pregnant women with serologically confirmed WNV illness reported to the Centers for Disease Control and Prevention. Comparison was made to WNV-uninfected women, matched on maternal age and enrollment month. Pregnancy and newborn data were collected; cord blood WNV serology was obtained. Pediatric exams and the Bayley Scales of Infant and Toddler Development-Third Edition (Bayley-III) were performed. RESULTS: Twenty-eight WNV-infected mothers and 25 WNV-uninfected mothers participated. Maternal demographics were similar except for a higher rate of planned pregnancies, education, and household income in the WNV-uninfected mothers. There were no differences in pregnancy and delivery characteristics except that infected mothers had a higher incidence of febrile illnesses and used more medications. Birth weight, length, head circumference, and rate of congenital malformations were similar in babies born to WNV-infected and -uninfected mothers. Follow-up physical exams were generally normal. The Bayley-III assessments, available for 17 children born to mothers with WNV illness, showed performance at or above age level across domains. CONCLUSION: The risk for adverse pregnancy and newborn outcomes in women experiencing WNV illness in pregnancy appears to be low, but future studies with larger numbers are needed to rule out a small risk. Birth Defects Research (Part A) 106:716-723, 2016.
Authors: Jan E Paisley; Alison F Hinckley; Daniel R O'Leary; William C Kramer; Robert S Lanciotti; Grant L Campbell; Edward B Hayes Journal: Pediatrics Date: 2006-03 Impact factor: 7.124
Authors: Patricia A Sirois; Gabriella Pridjian; Scott McRae; Alison F Hinckley; Sonja A Rasmussen; Patricia Kissinger; Pierre Buekens; Edward B Hayes; Daniel R O'Leary; Kenneth F Swan; Xu Xiong; Dawn M Wesson Journal: Birth Defects Res A Clin Mol Teratol Date: 2014-09-05
Authors: Edward B Hayes; James J Sejvar; Sherif R Zaki; Robert S Lanciotti; Amy V Bode; Grant L Campbell Journal: Emerg Infect Dis Date: 2005-08 Impact factor: 6.883
Authors: Derek J Platt; Amber M Smith; Nitin Arora; Michael S Diamond; Carolyn B Coyne; Jonathan J Miner Journal: Sci Transl Med Date: 2018-01-31 Impact factor: 17.956
Authors: Angelina Kakooza-Mwesige; Abdul H Mohammed; Krister Kristensson; Sharon L Juliano; Julius J Lutwama Journal: Front Neurol Date: 2018-02-23 Impact factor: 4.003
Authors: Juan P Aguilar Ticona; Nivison Nery; Joseph B Ladines-Lim; Claudia Gambrah; Gielson Sacramento; Bruno de Paula Freitas; Joseane Bouzon; Jamary Oliveira-Filho; Ana Borja; Haritha Adhikarla; Magelda Montoya; Athena Chin; Elsio A Wunder; Verena Ballalai; Carina Vieira; Rubens Belfort; Antonio R P Almeida; Mitermayer G Reis; Eva Harris; Albert I Ko; Federico Costa Journal: PLoS Negl Trop Dis Date: 2021-02-05
Authors: Franciane Mouradian Emidio Teixeira; Anna Julia Pietrobon; Luana de Mendonça Oliveira; Luanda Mara da Silva Oliveira; Maria Notomi Sato Journal: Front Immunol Date: 2020-02-14 Impact factor: 7.561